Understanding Cannabis — The Whole Truth

Cannabis is a flowering plant in the family Cannabaceae, a genus with a long and well-documented relationship with human civilization spanning at least 10,000 years. Botanists recognize it under the species name Cannabis sativa L. — the "L." honoring Carl Linnaeus, who first formally classified it in 1753.

It is a dioecious annual, meaning individual plants are typically either male or female. Female plants produce the resin-coated flowers — what most people call "buds" — that are harvested for their rich concentrations of cannabinoids and terpenes. Male plants produce pollen; growers cultivating for flower quality almost always remove males before pollination to keep females in an unfertilized, highly resinous state called sinsemilla (Spanish for "without seeds").

The plant grows with a central stalk and fan-shaped leaves with serrated leaflets — the iconic silhouette recognized the world over. Cannabis thrives across a remarkable range of latitudes and climates, from equatorial tropics to temperate mountain valleys, which over millennia has produced tremendous genetic diversity in the species.

The plant's life cycle runs from seed germination through a vegetative growth phase and then, triggered by light cycle changes (shorter days), into its flowering phase. Under natural conditions this happens as summer shifts to fall; indoor growers control it precisely by switching lighting schedules. The entire life cycle from seed to harvest typically spans 3–6 months depending on cultivar and growing method.

The word "marijuana" has no botanical meaning. It was popularized in the United States in the 1930s during the campaign to federally prohibit cannabis, and the term carried deliberate xenophobic connotations designed to associate the plant with immigrant communities. The word does not appear in any scientific taxonomy.

"Hemp" has a longer history — it historically referred to cannabis cultivated for fiber and industrial uses, plants typically low in intoxicating compounds. But like "marijuana," it describes a use category and a legal category, not a distinct species.

The modern legal distinction in the United States traces directly to the 2018 Farm Bill, which defined hemp as Cannabis sativa L. with a delta-9 THC concentration of 0.3% or less on a dry weight basis (DWB). A plant with 0.29% delta-9 THC is federally legal hemp. A plant with 0.31% is a Schedule I controlled substance. The plant itself — its seeds, genetics, biology, and chemistry — is identical in every other respect.

This distinction matters because the same compound — THCa — that gives our flower its potency exists in dispensary cannabis and in farm-direct cannabis alike. The delta-9 THC at harvest is what determines the legal classification. How a consumer experiences the product depends on the full cannabinoid and terpene profile, not on whether a label says "hemp" or "marijuana."

Cannabinoids are a class of chemical compounds produced almost exclusively in the trichomes of cannabis plants. They interact with the human body's endocannabinoid system (ECS) — a vast regulatory network of receptors, enzymes, and signaling molecules that exists throughout the brain, nervous system, immune system, and organs. The ECS helps regulate mood, pain response, appetite, sleep, inflammation, and dozens of other physiological functions.

The two primary receptor types are CB1 (concentrated in the brain and central nervous system) and CB2 (concentrated in immune tissue and peripheral organs). Different cannabinoids interact with these receptors — and with non-cannabinoid receptors — in different ways, producing distinct effects.

Here are the primary cannabinoids you'll encounter in cannabis:

Cannabis research has accelerated dramatically in the last two decades, and the science on individual cannabinoids — both converted and acidic forms — is more nuanced than most product marketing suggests. What follows is an honest summary of what peer-reviewed research and widespread user experience indicate about each compound's potential uses and properties.

Converted Cannabinoids

Acidic (Pre-Decarboxylation) Forms

The acidic cannabinoids are present in raw, unheated cannabis. They do not convert to their active forms until heat is applied. Research on acidic cannabinoids is newer and more limited than research on their converted counterparts — but what exists is genuinely interesting, especially for applications where users may be consuming raw cannabis (juicing, capsules, tinctures from unheated material).

Delta-9 THC is the most studied and most abundant psychoactive cannabinoid in cannabis — but it is one member of a larger molecular family. THC analogs differ from delta-9 in the position of a double bond, the length of a carbon chain, or both. These structural differences, which can seem minor on paper, produce significant differences in how each molecule binds to cannabinoid receptors, how potent it is, how long it lasts, and what kind of experience it produces.

Understanding these differences matters because the market is now full of hemp-derived THC analogs — many semi-synthetic, most made from CBD through chemical conversion — and the claims made about them are often more marketing than science. What follows is the honest molecular picture.

The THC Analog Family

Metabolized THC vs. Nano & Rapid-Release Formulations

How THC enters the body matters as much as how much you take. The same dose of THC can produce dramatically different onset times, peak intensities, durations, and overall experiences depending on the delivery mechanism. Understanding the three primary pathways — inhalation, standard oral/edible, and nanoemulsion — gives you the tools to make informed decisions about products and dosing.

Pathway 1 — Inhalation (Smoking or Vaporizing)

Pathway 2 — Standard Oral / Edible (Hepatic Metabolism)

Pathway 3 — Nanoemulsion & Rapid-Release Formulations

The cannabis market uses the words "natural," "semi-synthetic," and "synthetic" loosely — often interchangeably, almost always incorrectly. These are not marketing categories. They are precise chemical distinctions that carry real implications for safety, legality, and the accuracy of what you think you're consuming. Understanding them is one of the most important things a cannabis consumer can know.

The Semi-Synthetic Conversions — How They're Actually Made

Fully Synthetic Cannabinoids — A Different Category Entirely

Fully synthetic cannabinoids are not cannabis. They are laboratory-designed molecules built to activate cannabinoid receptors — sometimes with dramatically higher potency and no natural ceiling on their effects. The CB1 receptor cannot distinguish a synthetic cannabinoid from a natural one. It binds based on molecular shape alone. This is precisely what makes fully synthetic cannabinoids dangerous.

The cannabis plant doesn't produce cannabinoids arbitrarily. It builds them through a precise, enzyme-driven biochemical pathway that begins with basic carbon compounds and ends with the resin-filled trichomes we harvest. Understanding this pathway explains why some plants are naturally THC-dominant and others CBD-dominant, why young plants have different cannabinoid profiles than mature ones, and why the full spectrum of minor cannabinoids exists in the ratios it does.

• 1
  The MEP Pathway — Building the Carbon Skeleton

  All cannabinoids begin with the methylerythritol phosphate (MEP) pathway in the plant's plastids — the same pathway that produces terpenes and chlorophyll. The MEP pathway produces geranyl pyrophosphate (GPP), a 10-carbon building block that will form the terpene portion of the cannabinoid molecule. This is why cannabinoids are technically classified as terpenophenolics — they are hybrids of terpene and phenolic chemistry.
• 2
  Olivetolic Acid — The Phenolic Building Block

  Simultaneously, the polyketide pathway produces olivetolic acid — a phenolic compound with a 5-carbon alkyl chain (the same chain that determines potency in the THC analog family). Olivetolic acid is the phenolic half of the cannabinoid molecule. The enzyme olivetolic acid cyclase (OAC) is responsible for its formation. This is the step where the side chain length is determined — olivetolic acid has 5 carbons, producing standard cannabinoids; a heptyl variant would produce THCP-type cannabinoids.
• 3
  CBGa — The Mother Cannabinoid

  Geranyl pyrophosphate and olivetolic acid combine through the enzyme geranylpyrophosphate:olivetolate geranyltransferase (GOT) to produce cannabigerolic acid (CBGa). This is the central precursor — every major cannabinoid derives from CBGa. It is sometimes called the "stem cell" of the cannabinoid world. Young cannabis plants and early flowering stages have elevated CBGa because the downstream synthase enzymes haven't yet converted it fully.
• 4
  The Three Synthase Enzymes — Where Genetics Determines Chemotype

  CBGa is converted to the three major acidic cannabinoids by three separate oxidocyclase enzymes — and which enzymes a plant expresses, and in what quantities, is determined by its genetics:
  
  THCA Synthase (THCAS) converts CBGa → THCa. Plants that highly express THCAS become THC-dominant chemotypes.
  
  CBDA Synthase (CBDAS) converts CBGa → CBDa. Plants that highly express CBDAS become CBD-dominant chemotypes. The CBDAS and THCAS genes are allelic variants — a plant with two copies of the CBDAS gene will be CBD-dominant; one with two copies of THCAS will be THC-dominant; one with one of each will be mixed.
  
  CBCA Synthase (CBCAS) converts CBGa → CBCa. CBC expression is determined by how much of the CBCAS enzyme a plant produces relative to the other two.
• 5
  Decarboxylation — Heat Completes the Journey

  THCa, CBDa, and CBCa are the forms present in live and freshly harvested cannabis. Heat — from combustion, vaporization, or oven decarboxylation — removes the carboxyl group as CO₂ and water vapor, converting the acidic forms to their active counterparts: THC, CBD, CBC. This is not a plant process — it's a post-harvest transformation triggered by energy input. The plant never produces significant delta-9 THC on its own.

The term "entourage effect" has become one of the most cited and least understood concepts in cannabis. Most consumers have heard it. Almost none know the specific research behind it, the role of flavonoids (which most people have never heard of), or the fact that one common terpene directly binds cannabinoid receptors — making it pharmacologically active, not just aromatic.

Dr. Ethan Russo's 2011 paper "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid interactions" in the British Journal of Pharmacology is the foundational document for understanding the entourage effect in cannabis specifically. Russo documented specific synergies between cannabinoids and terpenes that produce measurably different outcomes than either compound alone:

Beta-Caryophyllene — The Terpene That's Also a Cannabinoid

This is the fact that stops most self-described cannabis experts cold. Beta-caryophyllene (BCP) is the only terpene known to directly bind cannabinoid receptors. Specifically, it is a selective CB2 agonist — it binds CB2 receptors in immune tissue with meaningful affinity. This makes it simultaneously a terpene (it's produced by the plant's terpene biosynthesis pathway and is responsible for the spicy, peppery, woody aroma common in many cultivars) and a dietary cannabinoid (it's found in black pepper, cloves, and hops, and it activates the endocannabinoid system through CB2).

Flavonoids — The Overlooked Third Pillar

Almost every discussion of the entourage effect focuses on cannabinoids and terpenes. Flavonoids are rarely mentioned — which is a significant omission. Cannabis produces over 20 identified flavonoids, including several found nowhere else in nature called cannaflavins.

Most cannabis consumers know that CB1 receptors are in the brain and CB2 receptors are in immune tissue. That's where most people's knowledge of the endocannabinoid system ends. The reality is significantly more complex, more interesting, and more relevant to understanding why cannabis affects the body the way it does.

Retrograde Signaling — The ECS Works Backwards

The Full ECS — Beyond Two Receptors

Clinical Endocannabinoid Deficiency — Russo's Hypothesis

In 2004, Dr. Ethan Russo proposed the Clinical Endocannabinoid Deficiency (CECD) hypothesis — the idea that some individuals produce insufficient endocannabinoids, leading to a dysfunctional ECS that manifests as specific clinical conditions. The conditions he identified as potential CECD presentations share several features: they are poorly understood, treatment-resistant, often co-occurring, and show improvement with cannabis.

Harvest is not the end of cannabis production — it's the beginning of a second, equally important phase. Curing is the controlled process of slowly drying and aging harvested cannabis under specific temperature and humidity conditions to complete a series of biochemical transformations that dramatically affect the quality, flavor, smoothness, potency stability, and overall experience of the final product.

Most consumers treat "fresh" as synonymous with "best." In cannabis, this is often wrong. Properly cured cannabis from two months ago will typically outperform improperly cured cannabis from last week in aroma complexity, smoke quality, and stability.

• 1
  Initial Dry — 7 to 14 Days

  Harvested branches or individual buds hang in a controlled environment: typically 60–65°F (15–18°C), 55–65% relative humidity, with gentle air circulation and complete darkness. Darkness matters — light degrades THCa to CBNa. The goal is slow drying: too fast (low humidity, high heat) locks in chlorophyll and harshness; too slow (high humidity) risks mold. The stem snap test — a small stem snapping cleanly rather than bending — indicates moisture has dropped to an appropriate level for jarring.
• 2
  Jar Cure — 4 to 8 Weeks Minimum

  Trimmed buds are placed in sealed glass jars at approximately 58–62% relative humidity. For the first two weeks, jars are "burped" — opened briefly once or twice daily — to release accumulated CO₂ and moisture and introduce fresh oxygen. This maintains the aerobic environment needed for enzymatic activity without allowing humidity spikes. After two weeks, burping frequency decreases. The flavor, aroma, and smoothness of properly jar-cured cannabis improve measurably through 6–8 weeks and can continue improving for months with premium genetics.
• 3
  Humidity Control — The Boveda Science

  Two-way humidity control packets (Boveda is the most widely used brand) use a saturated salt solution sealed in a semipermeable membrane to both absorb and release moisture to maintain a precise relative humidity level — most commonly 58% or 62%. The 58% target preserves terpenes that might otherwise volatilize at higher humidity, but can make material feel slightly dry. The 62% target maintains a more supple texture and may preserve certain terpene compounds better. The difference is meaningful — terpenes are volatile, and even a few percentage points of humidity affects how quickly they evaporate from stored material.
• 4
  Long-Term Storage — Freezing and Degradation

  THCa degrades to CBNa (and THC degrades to CBN) through oxidation and UV exposure over time. Properly stored cannabis — dark, cool, sealed — degrades slowly. For long-term preservation beyond 6 months, freezing in vacuum-sealed containers halts enzymatic activity and oxidation almost entirely. However, freezing also makes trichomes brittle — frozen cannabis should not be handled until it returns to room temperature or trichomes will break off mechanically. CBN content is the most reliable indicator of age and storage quality — rising CBN on a COA suggests improper storage or excessive age.

A Certificate of Analysis (COA) is the most important document in cannabis commerce — and most consumers don't know how to read one properly. They look at THCa percentage and move on. That's the equivalent of reading only the title of a book. A COA contains an enormous amount of information about product quality, safety, and integrity — if you know where to look and what questions to ask.

• 1
  Cannabinoid Panel — Beyond the THCa Number

  The cannabinoid panel reports all measured cannabinoids as percentages of dry weight. Key numbers:
  
  THCa % — the primary potency indicator for flower. What you're actually consuming when you smoke or vaporize.
  
  Delta-9 THC % — the legal compliance number. Must be ≤0.3% DWB for federal hemp compliance. If this number is above 0.3%, the product is legally marijuana regardless of THCa content.
  
  Total THC — calculated as (THCa × 0.877) + delta-9 THC. The 0.877 accounts for mass lost during decarboxylation. This is the most meaningful potency number for a consumer.
  
  CBD, CBG, CBC, CBN — the minor cannabinoid profile. Elevated CBN (above 0.5%) can indicate age or improper storage. CBG and CBC contribute to the entourage effect.
• 2
  Testing Method — HPLC vs. GC

  This is one of the most important and least understood details on a COA. Two primary methods are used for cannabinoid testing:
  
  HPLC (High Performance Liquid Chromatography) — tests at room temperature, preserving the acidic forms (THCa, CBDa). Reports THCa and delta-9 THC separately. This is the correct method for compliance testing and the method required under the Farm Bill.
  
  GC (Gas Chromatography) — requires heating the sample, which decarboxylates all THCa to THC before analysis. A GC test cannot distinguish THCa from delta-9 THC — it reports only total THC. This method is problematic for hemp compliance testing because it will show a high THC number even for a compliant product. Avoid COAs that use GC for cannabinoid testing on hemp flower.
• 3
  Terpene Panel — Reading the Flavor and Effect Profile

  A full terpene panel lists individual terpenes and their percentages. Total terpene content above 2% is generally considered excellent for flower. Key terpenes to identify:
  
  Myrcene — dominant in most cultivars, earthy/musky, associated with sedating effect profiles and potentially enhanced THC uptake.
  
  Limonene — citrus, associated with mood elevation and anti-anxiety effects.
  
  Beta-Caryophyllene — spicy/peppery, the only CB2-binding terpene, anti-inflammatory.
  
  Linalool — floral/lavender, GABA-A modulation, calming.
  
  Terpinolene — fresh/herbal, often dominant in sativa-leaning cultivars, associated with energizing effects.
  
  The ratio and balance of terpenes is as diagnostically useful as the total — two cultivars with 2% total terpenes but different dominant terpenes will produce measurably different experiences.
• 4
  Pesticide Panel — What to Look For

  A full pesticide panel tests for 60–100+ pesticide residues. Results are reported as pass/fail against action limits (typically set by the state). Key things to verify:
  
  Look for "ND" (not detected) or "Pass" on all tested pesticides. Any detected pesticide above the action limit is a fail and should disqualify the product.
  
  Note which pesticides were tested — a limited panel (testing only 20 compounds) is less reassuring than a comprehensive panel (80+). Ask if the laboratory tests for bifenazate, abamectin, and myclobutanil specifically — these are among the most commonly misused in cannabis cultivation.
  
  Myclobutanil is particularly concerning: when combusted, it converts to hydrogen cyanide. Legal in many agricultural applications, it has no business in cannabis that will be smoked.
• 5
  Heavy Metals — The Cannabis Bioaccumulation Problem

  Cannabis is a hyperaccumulator — it absorbs heavy metals from soil more efficiently than most plants (this is why it was grown near Chernobyl for phytoremediation). This makes heavy metal testing non-optional for cannabis flower grown in soil. A legitimate COA tests for lead, arsenic, cadmium, and mercury at minimum. Action limits vary by state but any detectable lead or mercury above 0.5 ppm warrants concern. Hydroponic and coco-grown cannabis has lower heavy metal risk, but soil-grown product must be tested.
• 6
  Microbial Testing — Mold, Yeast, and Pathogens

  A full microbial panel tests for total yeast and mold (TYMC), total aerobic count (TAMC), and specific pathogens including Aspergillus species (A. fumigatus, A. flavus, A. niger, A. terreus), E. coli, and Salmonella. This panel is critical for immunocompromised consumers — Aspergillus mold on cannabis can cause aspergillosis, a serious and potentially fatal lung infection in patients with weakened immune systems. Any detectable Aspergillus above action limits is an automatic fail. TYMC above 10,000 CFU/g generally indicates improper curing or storage conditions.

Inhalation and edibles represent most consumers' entire knowledge of cannabis consumption methods. The full picture is considerably broader — and the differences in bioavailability, onset, duration, and mechanism between methods are clinically significant.

This chapter contains information that may be more immediately important to some readers than anything else in this portal. Cannabis — particularly CBD — interacts with the liver enzyme system responsible for metabolizing a significant proportion of all pharmaceutical medications. These interactions are documented, clinically meaningful, and poorly communicated by both the cannabis industry and many healthcare providers.

This information is educational and does not constitute medical advice. If you take prescription medications, consult with your prescribing physician before using cannabis products. The drug interaction information above reflects published pharmacological research; individual responses vary and your physician can assess your specific situation.

This is one of the most important and most misunderstood aspects of cannabis chemistry — and it directly determines how you experience our products.

Cannabis does not actually produce significant amounts of THC, CBD, or CBG in living plant tissue. Instead, it produces their acidic precursor forms: THCa, CBDa, and CBGa. These acidic forms have an extra carboxyl group (COOH) attached to the molecule — which is why they're called "acidic" — and this structural difference fundamentally changes how they interact with the human body.

This is why eating raw cannabis flower produces very little psychoactive effect — there's almost no THC present yet. But smoking or vaporizing it — or infusing it into butter or oil after oven decarboxylation — converts the THCa to THC and produces the full effect.

What this means for our products and the law: A cannabis plant at harvest contains mostly THCa, not THC. The 2018 Farm Bill's 0.3% delta-9 THC threshold is measured at harvest in the raw plant material — before decarboxylation. So a flower with 25% THCa and 0.25% delta-9 THC is legally compliant hemp at harvest, even though smoking that flower delivers the full THCa-to-THC conversion.

The acidic forms are not without their own interest — THCa shows anti-inflammatory and neuroprotective properties in preliminary research, and CBDa may have distinct effects from CBD. But for the psychoactive experience most consumers are seeking, decarboxylation is the essential transformation.

The acidic cannabinoid compounds you'll see reported on our COAs:

Terpenes are aromatic compounds produced in the same trichomes as cannabinoids — and cannabis produces them in extraordinary abundance and variety. They're responsible for the distinct smell of each cultivar: the sharp citrus of a Lemon cultivar, the diesel fuel of a Sour Diesel, the berry sweetness of a Blueberry, the sharp pine of a Jack Herer.

But terpenes are more than fragrance. They interact with cannabinoid receptors, serotonin pathways, and dopamine systems in ways that appear to modulate the character of a cannabis experience — not just its intensity. This is a central mechanism behind the entourage effect.

Common terpenes and their characteristic notes:

Terpenes are volatile and temperature-sensitive. This is why vaporizing at lower temperatures is said to preserve more terpene expression than combustion, and why freshly cured flower with its terpenes intact smells dramatically more complex than older material. Our COAs include terpene profiles so you can see exactly what's present in each cultivar we carry.

The environment in which cannabis is grown profoundly shapes the quality, character, and chemistry of the final flower. Different cultivation methods offer different tradeoffs between control, scale, sustainability, and expression of the plant's full genetic potential.

Beyond the basic environment, cultivation decisions around soil vs. hydroponic vs. aeroponic growing, organic inputs vs. synthetic fertilizers, training techniques (SCROG, LST, topping), and drying and curing methods all contribute significantly to the final product's quality. We evaluate our farm partners on all of these factors, not just cannabinoid numbers.

Walk into any cannabis dispensary or read any cannabis product description and you'll encounter two words constantly: indica and sativa. These terms were originally botanical — Carl Linnaeus described Cannabis sativa in 1753, and Jean-Baptiste Lamarck later proposed Cannabis indica as a separate species for plants he observed in India. Whether these represent truly distinct species or simply varieties of the same species remains debated among botanists.

What is not debated: the popular consumer meaning of "indica" and "sativa" is largely marketing, not science. The widespread belief that all indicas sedate and all sativas energize is not supported by the chemistry. Modern cannabis genetics are so thoroughly hybridized that almost no commercial cultivar is a "true" indica or sativa in any meaningful sense. What determines the character of a cultivar's effect is the full cannabinoid and terpene profile — not its leaf shape or geographic origin story.

A note on terminology: the technically correct term for a selectively bred cannabis variety is cultivar (short for "cultivated variety") — the word "strain" is borrowed from microbiology and is technically inaccurate for plants, though it's used so universally in the cannabis world that it's understood by everyone.

The broad categories of cannabis genetics you'll encounter:

If you've ever looked closely at a cannabis flower and noticed the glistening, crystal-like coating that gives it a frosty appearance — you're seeing trichomes. These microscopic, mushroom-shaped structures are the biological factories that produce essentially everything valuable about cannabis: cannabinoids, terpenes, flavonoids.

Trichomes are so small they're barely visible to the naked eye — typically 50–500 micrometers in diameter. Under a loupe or microscope, a well-grown flower looks like a field of tiny glass mushrooms, each one a resin-filled gland attached to the plant by a thin stalk.

There are three types:

• 1
  Bulbous Trichomes

  The smallest type, visible only under magnification. Scattered across the entire plant surface. Contribute minimally to total cannabinoid content but are present everywhere.
• 2
  Capitate-Sessile Trichomes

  Medium-sized, more numerous than bulbous. Found across all plant surfaces. Contain meaningful amounts of cannabinoids and terpenes. Visible as a fine powder under moderate magnification.
• 3
  Capitate-Stalked Trichomes

  The largest and most abundant on the flowers themselves — the ones you see with a basic jeweler's loupe. These mushroom-shaped glands contain the highest concentrations of cannabinoids and terpenes. The head (capitulum) is essentially a resin balloon. These are what hash makers are separating from plant material when making concentrates.

Hash — or hashish — is one of the oldest cannabis preparations in human history, with documented use stretching back over a thousand years in Central Asia and the Middle East. At its core, hash is simply separated and concentrated trichome heads — the resin glands removed from plant material and compressed or processed into a concentrated form.

Because the trichomes are where virtually all cannabinoids and terpenes reside, good hash is a concentration of exactly those compounds, with the inert plant matter (cellulose, chlorophyll) largely removed. A high-quality hash can test 40–80% total cannabinoids or higher — compared to 15–35% in excellent flower.

The main categories of hash production:

Cannabis has been woven into American life since before the nation existed. Its suppression was not a natural consequence of scientific discovery — it was engineered, deliberately, by a small group of powerful men with financial and political motives. Understanding that history is essential context for understanding where we are today.

Cannabis has its own vocabulary — a mix of botanical science, street slang, regulatory language, and industry shorthand. Here are the terms you'll encounter most frequently with us.